Thursday, May 7, 2020

Petty champions the prevention of e-cigarette use in children

Melody Petty, M.D., MPH, FAAP, assistant professor of pediatrics at the University of South Alabama College of Medicine, was selected as the e-cigarette chapter champion for the Alabama Chapter of the American Academy of Pediatrics (AAP). In this role, she will serve as an advocate for the prevention of childhood nicotine use of products such as e-cigarettes.

E-cigarettes are electronic devices that heat a liquid and produce an aerosol, or mix of small particles in the air. Most e-cigarettes contain nicotine, the addictive drug also found in regular cigarettes and other tobacco products.

More than six million children are using tobacco products in the Unites States, according to recent estimates from the American Lung Association.

Petty, who also serves as a pediatric hospitalist for USA Health Children’s & Women’s Hospital, will represent the State of Alabama at a national kick-off meeting at the AAP national headquarters in the Chicago area this summer, said David A. Gremse, M.D., FAAP, Hollis J. Wiseman Distinguished Professor and Chair of the USA Department of Pediatrics.

“We are delighted Melody has committed her time and energy to represent our health system and state,” Gremse said. “E-cigarettes pose a serious health risk to our nation’s youth. As pediatric physicians, we play a vital role in protecting children from such dangers.”

As a state pediatric champion, Petty will be tasked with leading local advocacy and educational initiatives related to youth e-cigarette prevention and addiction support. She will also learn strategies to address e-cigarette use with youth and families, and then take what they’ve learned to lead educational sessions and communication activities back in Mobile and across the state.

The in-person training gives participants access to the academy’s new evidence-based e-cigarette curriculum as well as a hands-on media and communications training. The initial commitment is for 12 months, with the option to continue in this role every two years.

Surgery and pharmacology faculty member featured in ACCESS Magazine

Jon Simmons, M.D., FACS, associate professor of surgery and pharmacology at the University of South Alabama College of Medicine, was recognized in the April issue of ACCESS Magazine, which focuses on wellness and top doctors in the Gulf Coast area.

“It’s always an honor to have the accomplishments of our trauma center highlighted within the community that we are so proud to serve,” said Simmons, who is the medical director for trauma and acute care surgery at USA Health.

Charla Evans, D.O., family medicine physician at USA Health Hillcrest Primary Care, was also included in the issue.

“We chose Dr. Simmons and Dr. Evans to be in our Top Doctors On The Bay special issue simply because they are revered by everyone,” said Hayley Hill, ACCESS editor-in-chief. “From patients to peers, they are known not only for their professional talents and achievements, but for their genuine kindness as well.”

See the Top Doctors issue of ACCESS Magazine here.

Tuesday, May 5, 2020

New addiction medicine fellowship first of its kind in Alabama

J. Luke Engeriser, M.D., associate professor of psychiatry,
speaks with family members at AltaPointe.
The University of South Alabama College of Medicine is collaborating with AltaPointe Health to offer a fellowship in addiction medicine. The new program is the first in the state to receive accreditation from the Accreditation Council for Graduate Medical Education (ACGME) to train and provide a pipeline for the next generation of addiction medicine experts in the state of Alabama.

“Our nation has experienced unprecedented levels of problems related to addiction during the opioid epidemic, and physicians with expertise in addiction medicine are in very short supply in the United States generally and in Alabama in particular,” said J. Luke Engeriser, M.D., associate professor of psychiatry. “Early evidence shows that problems related to addiction to alcohol and other drugs have been exacerbated during the COVID-19 pandemic, so high-quality addiction treatment will be in even greater demand in the coming years.”

“This will be a benefit to all Alabamians as there are few of us that are not touched in some way by addiction either in ourselves or in people that we care about,” Engeriser added.

The new fellowship program will train physicians from any medical specialty to provide specialized care to individuals struggling with addictive disorders. The next step is to secure funding to begin the recruitment process for the first fellow. Engeriser is hopeful the fellowship could start as early as July 1, 2020.

In addition to Engeriser, core program faculty will include Ashlen Aggen, M.D.; Praveen Narahari, M.D.; Marianne Saitz, D.O.; and Lori Lowthert, M.D. Narahari, Saitz, Lowthert and Engeriser are board-certified in addiction medicine.

“We are fortunate at AltaPointe to have a team of physicians that demonstrate the ability to add value to everything we are doing with their dedication to serving patients, fighting addictions, and keeping up with the demands of the healthcare industry,” said Tuerk Schlesinger, chief executive officer of AltaPointe Health. “Obtaining the addiction medicine fellowship is a true testament to that dedication and hard work.”

The addiction medicine fellowship program is the latest collaboration between AltaPointe and the USA College of Medicine, a relationship that began in 2004 with the establishment of a psychiatry rotation for third-year College of Medicine students. The partnership grew to include a psychiatry residency program in 2007 and a child-adolescent psychiatry fellowship in 2014.

Thursday, April 30, 2020

Daniel to receive alumni award from UAB Public Health

A public health researcher at the University of South Alabama College of Medicine has been selected to receive the 2020 UAB School of Public Health Early Career Achievement Alumni Award.

Casey L. Daniel, Ph.D., M.P.H., was chosen for the award for demonstrating excellence in public health as an alumna of the UAB School of Public Health. She is an assistant professor of family medicine at the USA College of Medicine and works in the cancer control and prevention program at USA Health Mitchell Cancer Institute.

“Dr. Daniel is an excellent collaborator and excels in community engagement,” said Paul Erwin, M.D., dean of the UAB School of Public Health. “She exemplifies all the attributes of our graduates by ‘Being Somebody’ and ‘Making a Difference.’”

In her role at MCI, Daniel conducts epidemiological and intervention research and mentors undergraduates, graduate students and medical students. Her research focuses on the prevention of human papillomavirus-associated cancers, particularly improving adolescent HPV vaccination in rural and underserved populations. She has led initiatives that engage partners in pharmacy, dentistry, oncology, education and policy.

Daniel is the elected chair of the Alabama Comprehensive Cancer Control Coalition and appointed lead of the Data Work Group for the Alabama Adolescent Vaccination Task Force. She was selected as a 2019-2020 American Cancer Society ResearcHERs ambassador and serves on the ACS Alabama South Region Board of Directors. Daniel was recently named chairman of the board of directors for the organization VAX2STOP, a nonprofit working to reduce cancer risk in the Alabama through preventive care and education.

She is currently leading a project at USA Health compiling data that could provide insights into COVID-19 symptoms, the spread of the infection and its impact on Mobile-area residents, as well as serving on numerous COVID-19 tasks forces at USA and in the community.

Daniel’s research is funded by grants from the National Institutes of Health, the National Cancer Institute, the Breast Cancer Research Foundation of Alabama, the Health Resources & Services Administration, the Alabama Department of Public Health and other organizations. She has authored numerous scientific articles and is a frequent presenter at national and international meetings.

Phung, physician-scientist, joins pathology faculty at USA College of Medicine

Pathology allows Thuy Phung, M.D., Ph.D., to combine both of her passions: medicine and research.

The physician-scientist recently joined the University of South Alabama College of Medicine as an associate professor of pathology. She also serves as medical director of molecular pathology and dermatopathology at USA Health.

“I want to apply our knowledge and understanding of disease pathogenesis and laboratory diagnostics to patient care, and pathology fulfills that critical niche in medicine,” Phung said. “In today’s healthcare, molecular and genomic testing has increasingly important role in providing clinicians key information for the diagnosis and treatment of patients with infectious diseases and cancer, to name a few.”

Phung’s research area is the tumor microenvironment, which is the milieu in which cancer cells grow. This milieu consists of blood vessels, lymphatics, immune cells and the extracellular matrix, she said.

“Tumor cells and the surrounding microenvironment interact with each other, and this interaction plays a crucial role in tumor progression and metastasis,” she explained. “My particular research focuses on the molecular mechanisms that drive tumor cells to induce new blood vessel formation to feed their growth and distant spread.”

Her research also focuses on abnormal vascular growth and development in children, which give rise to a class of disorders called vascular anomalies. She said, “We have recently uncovered potential novel mechanisms of how these lesions develop by concurrently examining the entire cellular genome and protein repertoire in the cell.”

Phung said she is excited to be part of the USA College of Medicine and the Mobile community. “I chose to come to USA because I saw a great opportunity for professional growth and development at the university in general and in the department of pathology in particular,” she said. “I look forward to developing meaningful relationships with the USA community, and to a time when I can freely explore the charm of Mobile and its surrounding coastal areas.”

Prior to joining USA, Phung was an associate professor in the department of pathology and immunology at Baylor College of Medicine in Houston. She also served as a molecular pathologist, a dermatopathologist, and as the associate director of global pathology at Texas Children’s Hospital in Houston.

While a junior faculty member at Baylor, Phung teamed up with a group of physicians at Harvard Medical School and the University of Medicine and Pharmacy in Vietnam to establish a highly successful medical clinic to care for children with disfiguring vascular birthmarks in Ho Chi Minh City, Vietnam.

“This work has given me much confidence that an individual, with the right purpose and motivation as well as strong support from one's institutional leadership and colleagues, can make a huge impact for the good of others,” she said.

Phung earned her medical degree and Ph.D. in cell biology from the University of Rochester School of Medicine and Dentistry in Rochester, New York. She completed her residency training in anatomic pathology at Barnes-Jewish Hospital, Washington University, in St. Louis.

Phung completed a clinical fellowship in dermatopathology, followed by a postdoctoral research fellowship in vascular biology at Beth Israel Deaconess Medical Center and Harvard Medical School in Boston. She later completed a clinical fellowship in molecular genetic pathology at Houston Methodist Hospital in Houston.

She is a board-certified diplomate of the American Board of Pathology, the American Board of Medical Genetics and Genomics, and the American Board of Dermatology.